Recent Finacing
Recent Raise
AtG Therapeutics develops precision oncology medicines focused on a metabolic tumor target and patient-selector, advancing two programs—preclinical AtG‑153 and prototype AngioDxPredict—targeting renal, colorectal, and breast cancers.
